Chronic stress induces steatohepatitis while decreases visceral fat mass in mice

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Liu, Yun Zi ^a   Chen, Ji Kuai ^a   Zhang, Yi ^a   Wang, Xia ^a   Qu, Shen ^b   Jiang, Chun Lei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic stress; Homeostasis; Inflammation; Steatosis; Visceral fat

Indexed keywords

ADIPOCYTOKINE; CHOLESTEROL; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC STRESS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; FAT MASS; FEMALE; HISTOLOGY; INTRAABDOMINAL FAT; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ALLOSTASIS; ANIMAL; BODY WEIGHT; C57BL MOUSE; COMPLICATION; DISEASE MODEL; EXERCISE; FEEDING BEHAVIOR; INFLAMMATION; LIVER; MENTAL STRESS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ALLOSTASIS; ANIMALS; BODY WEIGHT; CHOLESTEROL; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; FEMALE; INFLAMMATION; INTRA-ABDOMINAL FAT; LIVER; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TRIGLYCERIDES;

EID: 84903123970     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-14-106     Document Type: Article

References (29)

1. Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
2. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010, 53:372-384.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009, 50:204-210.
4. Lomonaco R, Sunny NE, Bril F, Cusi K. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. Drugs 2013, 73:1-14.
5. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
6. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001, 34:1158-1163.
7. Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K, Nagaoka S, Matsumoto T, Takii Y, Kusumoto K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006, 26:39-45.
8. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 2007, 127:954-960.
9. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
10. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The, Hans Selye Memorial Lecture. Ann N Y Acad Sci 1997, 1998(851):311-335.
11. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006, 332:521-525.
12. Moles A, Bartolomucci A, Garbugino L, Conti R, Caprioli A, Coccurello R, Rizzi R, Ciani B, D'Amato FR. Psychosocial stress affects energy balance in mice: modulation by social status. Psychoneuroendocrinology 2006, 31:623-633.
13. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
14. Knepel W, Nutto D, Hertting G. Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology 1982, 34:353-356.
15. Blanc G, Herve D, Simon H, Lisoprawski A, Glowinski J, Tassin JP. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Nature 1980, 284:265-267.
16. Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, Saito H. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A 2002, 99:890-895.
17. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008, 27:412-421.
18. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006, 131:934-945.
19. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring) 2006, 14(Suppl 1):16S-19S.
20. Czech B, Neumann ID, Muller M, Reber SO, Hellerbrand C. Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. Int J Clin Exp Pathol 2013, 6:1585-1593.
21. Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, Hisatomi A, Ozaki I, Yamamoto K, Kitajima Y, Kawaguchi Y, Kuroki S, Ono N. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 2006, 41:462-469.
22. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006, 130:1848-1852.
23. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008, 48:449-457.
24. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006, 2:367-373.
25. Engl J, Sturm W, Sandhofer A, Kaser S, Tschoner A, Tatarczyk T, Weiss H, Tilg H, Patsch JR, Ebenbichler CF. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. Eur J Clin Invest 2008, 38:238-244.
26. Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2005, 21:702-707.
27. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 1989, 86:612-616.
28. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992, 148:2423-2428.
29. Devalaraja MN, Mcclain CJ, Barve S, Vaddi K, Hill DB. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 1999, 11:875-881.